CRISPR Therapeutics AG (CRSP) Social Stream



CRISPR Therapeutics AG (CRSP): $54.50

0.16 (+0.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRSP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

CRISPR THERAPEUTICS AG (CRSP) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRSP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 16 $220 $100 $160.266 $54.79 192.51%
2022-02-02 16 $220 $100 $160.692 $54.79 193.29%
2022-02-04 16 $220 $100 $158.846 $54.79 189.92%
2022-02-16 17 $220 $100 $157.714 $54.79 187.85%
2022-02-17 17 $220 $64 $154.785 $54.79 182.51%
2022-02-25 17 $220 $64 $153 $54.79 179.25%
2022-05-09 16 $220 $64 $152.461 $54.79 178.26%
2022-05-10 16 $220 $52 $150.692 $54.79 175.04%
2022-05-12 16 $220 $52 $140.714 $54.79 156.82%
2022-05-13 16 $220 $52 $139.466 $54.79 154.55%
2022-05-16 16 $220 $52 $137.8 $54.79 151.51%
2022-05-17 16 $220 $52 $132.533 $54.79 141.89%
2022-05-23 16 $220 $52 $128.2 $54.79 133.98%
2022-06-12 17 $220 $46 $123.062 $54.79 124.61%
2022-06-13 17 $220 $46 $123.375 $54.79 125.18%
2022-06-16 17 $220 $46 $123.375 $54.79 125.18%
2022-06-22 17 $220 $46 $121.882 $54.79 122.45%
2022-07-11 18 $220 $46 $116.888 $54.79 113.34%
2022-08-02 17 $220 $46 $118.555 $54.79 116.38%
2022-08-09 20 $220 $46 $118.555 $54.79 116.38%
2022-08-10 20 $220 $46 $116.833 $54.79 113.24%
2022-08-15 19 $220 $46 $114.187 $54.79 108.41%
2022-09-28 19 $220 $46 $114.312 $54.79 108.64%
2022-10-11 20 $220 $37 $109.764 $54.79 100.34%
2022-11-02 20 $220 $37 $107.833 $54.79 96.81%
2022-11-06 20 $220 $37 $103.944 $54.79 89.71%
2022-11-07 20 $220 $37 $104 $54.79 89.82%
2022-11-23 20 $220 $37 $102.888 $54.79 87.79%

The Trend in the Analyst Price Target


Over the past 45 weeks, CRSP's average price target has gone down $57.8.

CRSP reports an average of 118.03% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-16 16 220 52 137.800 51.54 167.37%
2022-06-22 17 220 46 121.882 59.94 103.34%
2022-07-11 18 220 46 116.888 73.71 58.58%
2022-08-15 20 220 46 114.187 80.14 42.48%
2022-11-07 20 220 37 104.000 49.70 109.26%

CRSP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.07 11 0 7 2 2 20

The Trend in the Broker Recommendations


Over the past 123 days, CRSP's average broker recommendation rating worsened by 0.6.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRSP as an investment opportunity.

  • CRISPR THERAPEUTICS AG's variance in analysts' estimates is lower than -3281.81% of all US stocks.
  • CRSP has a higher number of analysts covering the stock than 3377.9% of all US stocks.
  • CRSP has a higher average analyst price target than 3303.88% of Pharmaceutical Products stocks.
  • CRSP has a greater upside potential (average analyst target price relative to current price) than 3255.65% of stocks in the large market cap category.

Stocks similar to CRISPR THERAPEUTICS AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NVAX, NBIX, and TECH.

What is the outlook for CRSP? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6485 seconds.